Critical Care Analyzer with Micro Capillary Sample Mode Provides Major Blood-Saving Benefit
By HospiMedica International staff writers Posted on 05 Oct 2023 |

Excessive blood collection for lab tests in critically ill patients is known to be a significant cause of severe anemia and increased use of blood products. This, in turn, leads to longer hospital stays and higher mortality rates. Now, a novel blood gas analyzer featuring a micro capillary sample mode provides a major blood-saving benefit for the diagnostic testing of critically ill patients.
Nova Biomedical (Waltham, MA, USA) has received the U.S. Food and Drug Administration (FDA) 510(k) clearance for a micro capillary sample mode on its Stat Profile Prime Plus Critical Care analyzer. This new feature allows Prime Plus to perform an 11-test panel using only 90 microliters of capillary blood. Alternatively, a comprehensive 22-test profile can be done with just 135 microliters of blood. This sampling mode enhances Prime Plus's existing capabilities for conserving blood during diagnostic testing and is now a standard feature on all Prime Plus analyzers.
The Stat Profile Prime Plus boasts a state-of-the-art test menu for critical care, featuring a range of tests including pH, PCO2, PO2, SO2%, Na, K, iCa, iMg, Cl, TCO2, glucose, lactate, creatinine, urea, hematocrit, hemoglobin, MCHC, estimated plasma volume, CO-Oximetry panel, and 34 calculated results. The simple, compact analyzer uses maintenance-free, replaceable cartridges for sensors and reagents, along with patented, maintenance-free, whole blood CO-Oximetry technology. The device's ability to use small-volume microcapillary blood collection tubes eliminates sample over-draws, dead volume, and waste typically associated with syringe or vacuum tube methods. Moreover, Prime Plus allows for scheduled bundling of tests, reducing the number of times blood needs to be drawn as well as the variety of containers used, thereby minimizing blood drawn for critical care testing.
"Prime Plus microsample volume and comprehensive test menu provide a major blood-saving benefit for diagnostic testing of critically ill patients,” said Terry Austin, Sales Product Line Manager for Prime Plus analyzer. “Prime Plus delivers gases, electrolytes, glucose, lactate, hematocrit, or any subset of these tests on just two drops (90 microliters) of blood. A basic metabolic panel of electrolytes, glucose, lactate, creatinine, urea, and hematocrit is available on 135 microliters, 1/50th the volume of blood needed for the same tests in the central laboratory."
Related Links:
Nova Biomedical
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
Battery-Powered Wearable Device Monitors Joint Pain
Ankle injuries are common among active Americans. Each day, approximately 25,000 people experience ankle sprains, and 25% of Americans regularly deal with knee pain. However, physical therapy can be both... Read more
Wireless Pacifier Monitors Vitals of NICU Babies Without Need for Painful Blood Draws
Newborns require frequent monitoring of their vital signs, with electrolyte levels being one of the most important indicators of their health. Currently, the only method to monitor these levels is through... Read moreSurgical Techniques
view channel
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read more
Spectroscopy Technique Improves Surgery for Pediatric Epilepsy Patients
Epilepsy affects over 50 million people globally, with approximately half of them being children. For about one-third of these patients, seizures remain uncontrolled by medications, making surgery the... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more